<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>PMC</source><date>20201214</date><key>pmc.key</key><document><id>29017</id><infon key="license">NO-CC CODE</infon><passage><infon key="article-id_pmc">29017</infon><infon key="article-id_pmid">11056727</infon><infon key="article-id_publisher-id">cc-3-3-071</infon><infon key="fpage">71</infon><infon key="issue">3</infon><infon key="journal-title">Critical Care</infon><infon key="kwd">adrenal insufficiency anaphylaxis cirrhosis hypotension pancreatitis sepsis systemic vascular resistance</infon><infon key="lpage">77</infon><infon key="name_0">surname:Melo;given-names:Jairo</infon><infon key="name_1">surname:Peters;given-names:Jay I</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">3</infon><infon key="year">1999</infon><offset>0</offset><text>Low systemic vascular resistance: differential diagnosis and 		  outcome</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>73</offset><text>Objective:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>84</offset><text>To determine the frequency and prognosis of the various causes of 				low systemic vascular resistance (SVR).</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>194</offset><text>Design:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>202</offset><text>Analysis of consecutive patients over a 5-year period; 				retrospective review.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>283</offset><text>Setting:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>292</offset><text>Medical intensive care unit of a large university hospital.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>352</offset><text>Patients:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>362</offset><text>Fifty-five patients with unexplained hypotension and a SVR less 				than 800 dynes × s/cm5.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>458</offset><text>Background:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>470</offset><text>There are minimal data in the medical literature determining the 				frequency or outcome of patients with a low SVR that is unrelated to sepsis or 				the sepsis syndrome. We retrospectively reviewed and analyzed all hemodynamic 				data in a large university hospital over a 5-year period to determine the 				frequency and prognosis of the various causes of low SVR. Fifty-five patients 				with unexplained hypotension and a SVR less than 				800dynes×s/cm5were identified.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>949</offset><text>Main results:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>963</offset><text>Twenty-two patients (Groups 1 and 2) met the criteria for sepsis 				syndrome. The mean SVR for this group was 445 ± 				168 dynes×s/cm5 with an associated mortality of 50%. Group 3 				contained 20 patients with possible sepsis. Thirteen patients (Group 4) were 				nonseptic. The mean SVR of this group was 435 ± 				180 dynes × s/cm5 with an associated mortality of 46%. Extremely 				low SVR (below 450 dynes × s/cm5) was associated with a 				significantly higher mortality regardless of the etiology.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>1475</offset><text>Conclusions:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1488</offset><text>At least a quarter of patients with hypotension and a low SVR have 				nonseptic etiologies. The patients with nonseptic etiologies have a similar 				mortality to septic patients. Clinicians should be aware of the wide spectrum 				of conditions that induce a low SVR.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1758</offset><text>Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1771</offset><text>As initially described by Poiseuille's law, resistance to flow 		  is that resistance provided by a vessel or circulatory bed which permits a 		  given pressure differential to produce a unit flow. Transcribed to human 		  hemodynamics, systemic vascular resistance (SVR) can be measured from the 		  differential pressure between the mean arterial pressure (MAP) and the central 		  venous pressure (CVP) divided by the flow, ie cardiac output (CO). Although 		  many clinical conditions can cause a low SVR, septic shock remains the most 		  common cause and usually results in a severe decrease in SVR. In more than 90% 		  of patients with septic shock who are aggressively volume loaded, the CO is 		  initially normal or elevated. Therefore, hypotension results from reduced 		  vascular resistance with normal or elevated CO. This form of shock results from 		  maldistribution of blood flow to tissues, usually from acute vasodilatation 		  without concomitant expansion of the intravascular volume. While distributive 		  shock can also be caused by anaphylaxis, drug ingestion, neurogenic injury, and 		  adrenal insufficiency, these conditions are seen with less frequency in the 		  intensive care unit. Therefore, a hemodynamic state with low SVR is often 		  considered synonymous of sepsis, and other conditions associated with a low SVR 		  may not be considered.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3151</offset><text>There are minimal data in the medical literature assessing the 		  frequency or outcome of patients with distributive shock that is unrelated to 		  sepsis or the sepsis syndrome. Since we could find no prior studies in the 		  literature assessing the etiology and outcome of hypotensive patients with a 		  low SVR, we reviewed our experience with patients undergoing hemodynamic 		  monitoring in the medical intensive care unit of a large university hospital. 		  The purpose of this study was to determine the different causes of low SVR, 		  identify prognostic factors, and analyze the mortality of these various groups 		  of patients.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>3795</offset><text>Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>3803</offset><text>After approval by the Institutional Review Board of the University of 		  Texas Health Science Center at San Antonio, medical records of all patients 		  admitted to the medical intensive care unit of the University Hospital between 		  1990–1995 were reviewed. All the charts of patients undergoing pulmonary artery 		  catheterization were identified. Patients with a recorded SVR less than 		  800 dynes ×s/cm5 were analyzed. The main indication for pulmonary 		  artery catheterization in patients in this study was unexplained hypotension 		  after volume challenge. Any patient with an unclear etiology for hypotension or 		  any patient requiring more than 10 μ g/kg/min dopamine underwent pulmonary 		  artery catheterization and was reviewed for this study. Anxiolytics, sedatives, 		  and neuromuscular blocking agents are administered by protocol and have minimal 		  or no direct effects on hemodynamics or histamine release. Cultures of blood 		  and urine were obtained on all patients; cultures of sputum, pleural fluid, 		  ascitic fluid, and cerebrospinal fluid were obtained as clinically indicated. 		  Toxicological screening of blood and urine for drugs was performed on admission 		  if the etiology of hypotension was in question. Serum cortisol level 		  determination was performed on all patients receiving exogenous corticosteroids 		  or in patients with known risk factors for adrenal insufficiency. Hematologic 		  and blood chemistry determinations, arterial blood gases, routine urinalysis, 		  and serial electrocardiograms were obtained on all patients.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>5395</offset><text>Mean systemic, right atrial, and pulmonary artery pressures and 		  thermodilution cardiac outputs were measured every 4 h in all patients. Derived 		  hemodynamic variables were calculated as follows: cardiac index (CI; 		  l/min/m2) = CO/body surface area; SVR 		  (dynes × s/cm5)=(80× MAP)/CO; and systemic vascular 		  resistance index (SVRI)=SVR/body surface area. Patients received vasopressors 		  to maintain MAP above 70 mmHg. The set of hemodynamic data with the lowest SVR 		  was selected for each patient.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>5916</offset><text>All historical, clinical, laboratory, microbiologic, and hemodynamic 		  data were studied. Patients were divided into four groups based on the 		  following parameters: (1) positive blood culture; (2) temperature ≥                 		  38.1°C or ≤ 36°C; (3) white blood counts (WBCs) ≥ 		  12000/mm3 or ≤ 4000/mm3; and (4) obvious source of 		  infection. Group 1 (definite sepsis) had positive blood cultures and two or 		  more criteria; Group 2 (probable sepsis) had an obvious source of infection and 		  two or more additional criteria; Group 3 (possible sepsis) had fever and 		  leukocytosis or leukopenia with no obvious source of infection nor positive 		  blood culture; and Group 4 (nonseptic) had none of the criteria.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6657</offset><text>The clinical course, laboratory findings, hemodynamics, and intensive 		  care unit mortality were compared between the various groups. Data are 		  expressed as mean ± standard deviation. Clinical and hemodynamic variables 		  were compared with a student's t-test and by analysis of 		  variance to assess statistical significance between groups. Logistic regression 		  analysis was performed comparing SVR and death using a univariant analysis.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7107</offset><text>Mortality was assessed by Mann-Whitney rank sum test. A P 		  value of ≤ 0.05 was considered statistically significant.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>7229</offset><text>Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7237</offset><text>Fifty-five patients were included in the study (Table 1). Group 1 contained 18 patients with definite sepsis; Group 2 		  contained four patients with probable sepsis; Group 3 contained 20 patients 		  with possible sepsis; and Group 4 contained 13 patients who had no evidence of 		  sepsis. The mean age of the patients was 50 ± 13.6years. Thirty-four 		  patients were men, and 21 patients were women. The overall MAP was 72 ± 		   20 mmHg at the moment the hemodynamic values were chosen. The overall mean CO 		  was 9.2 ± 6.18l/min, and the mean CI was 5.1 ± 1.7l/min/m2. 		  The overall mean SVR was 435 ± 180 dynes × s/cm5; the mean 		  SVRI was 785 ± 325 dynes × s/cm5. Analysis of SVRI was 		  reviewed for each subgroup and not found to be different from the analysis of 		  SVR; therefore, only data for SVR are presented.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8079</offset><text>There were no statistically significant differences in age, sex, or 		  admission temperature among the different groups. Twenty-two patients (Groups 1 		  and 2) met the criteria for the sepsis syndrome. The 		  mean SVR was 445 ± 168 dynes × s/cm5, CO was 10.86 ± 		  5.22l/min; and CI was 5.08 ± 1.64l/min/m2 for this group. The 		  overall mortality in those patients classified as having the sepsis syndrome 		  was 50%. In patients with the sepsis syndrome, the lung was the primary site of 		  infection in 14 out of 22 patients. Thirteen patients were considered nonseptic 		  (Group 4). This group had no source of infection, alteration in temperature, 		  leukocytosis, or leukopenia. The mean hemodynamic values for this group were: 		  SVR = 435 ± 180 dynes × s/cm5; CO = 9.23 ± 4.24l/min, and 		  CI = 7.72 ± 1.9l/min/m2. The mortality was 46%. There were no 		  statistically significant differences in any hemodynamic values nor in 		  mortality between the nonseptic group (Group 4) and the groups with sepsis 		  syndrome (Groups 1 and 2). The nonseptic group included eight patients with 		  intra-abdominal disease (five with decompensated cirrhosis, three with acute 		  pancreatitis), one patient with adrenal insufficiency, and four patients with 		  unclear etiologies for hypotension and low SVR (idiopathic). The mortality in 		  patients with decompensated intra-abdominal disease was 75% (six out of eight). 		  Additionally, no statistically significant difference in any of the hemodynamic 		  values or mortality was identified between the four groups when analyzed 		  individually (Table 2).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>9711</offset><text>Twenty-seven patients met the criteria for the extreme hyperdynamic 		  state (EHS). In the literature, EHS is defined as an 		  SVR below 450 dynes × s/cm5 and a CO above 7l/min/m2. 		  The mean hemodynamic values for patients in this study with EHS were: SVR = 		  327± 85 dynes × s/cm5; CO = 12.13 ± 3.31l/min; and CI = 		  5.98 ± 1.46 l/min/m2. Seven of these patients had a diagnosis of 		  underlying cirrhosis. Twelve of the patients within this group were diagnosed 		  with sepsis syndrome, 10 with possible sepsis, and five were nonseptic. This 		  group had a statistically significant higher mortality (60% versus 33%) than 		  those patient without the EHS (P &lt; 0.05). A univariant logistic 		  regression was performed analyzing the level of reduction of SVR and mortality. 		  A statistically significant relationship was found between these variables 		  (P = 0.025). For every reduction in SVR of 50dynes × 		  s/cm5, there was a 20% increase in mortality (odds ratio = 1.2; 		  range = 1.022-1.434).</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>10735</offset><text>Clinical parameters of study groups</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align=&quot;center&quot;&gt;Age&lt;sup&gt;a&lt;/sup&gt;&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;Temperature&lt;sup&gt;b&lt;/sup&gt;&lt;/td&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Group&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;Number&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;(mean ± SD)&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;(mean ± SD)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Clinical diagnoses&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Group 1: definitive sepsis&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;18&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;52 ± 12&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;101.5 ± 1.6&lt;sup&gt;°&lt;/sup&gt; F&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Pneumonia (10); urinary tract infection (3); abdominal&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align=&quot;left&quot;&gt;sepsis (2); toxic shock syndrome (1); meningitis (1);&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align=&quot;left&quot;&gt;cellulitis (1)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Group 2: probable sepsis&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;4&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;48 ± 10&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;99.3 ± 4.17&lt;sup&gt;°&lt;/sup&gt; F&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Pneumonia (4)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Group 3: possible sepsis&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;20&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;51 ± 12.5&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;100.3 ± 2.36&lt;sup&gt;°&lt;/sup&gt; F&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Spontaneous bacterial peritonitis (5); idiopathic (3)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Group 4: nonseptic&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;13&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;44 ± 17&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;98.4 ± 1.8&lt;sup&gt;°&lt;/sup&gt;F&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Cirrhosis (5); idiopathic (4); pancreatitis (3); adrenal&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align=&quot;left&quot;&gt;insufficiency (1)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>10771</offset><text>		Agea	Temperatureb		 	Group	Number	(mean ± SD)	(mean ± SD)	Clinical diagnoses	 	Group 1: definitive sepsis	18	52 ± 12	101.5 ± 1.6° F	Pneumonia (10); urinary tract infection (3); abdominal	 					sepsis (2); toxic shock syndrome (1); meningitis (1);	 					cellulitis (1)	 	Group 2: probable sepsis	4	48 ± 10	99.3 ± 4.17° F	Pneumonia (4)	 	Group 3: possible sepsis	20	51 ± 12.5	100.3 ± 2.36° F	Spontaneous bacterial peritonitis (5); idiopathic (3)	 	Group 4: nonseptic	13	44 ± 17	98.4 ± 1.8°F	Cirrhosis (5); idiopathic (4); pancreatitis (3); adrenal	 					insufficiency (1)	 	</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>11360</offset><text>aP &gt; 0.05; bP &lt;
				0.01, between Group 1 + 2 versus Group 4</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>11421</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>11432</offset><text>Sepsis and sepsis syndrome were the most common etiologies of a low 		  SVR in this study. Although many studies have found urinary or intra-abdominal 		  sepsis to be the most common cause of low SVR, the 		  lung was the primary site of infection in over half of our patients.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>11711</offset><text>Septic shock, the leading cause of intensive care unit mortality, is 		  caused by systemic activation of the inflammatory cascade. Numerous mediators, 		  including cytokines, kinins, complement, coagulation factors, and eicosanoids, 		  are activated or systematically released, resulting in profound disturbances of 		  cardiovascular and organ system function. These mediators, particularly tumor 		  necrosis factor (TNF), interleukin (IL)-1, platelet activating factor, and 		  prostaglandins, are thought to mediate the reduced peripheral vascular 		  resistance seen in septic shock.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>12303</offset><text>Parker et al studied serial 		  cardiovascular variables in humans with septic shock. A low SVR was seen in 		  both survivors and nonsurvivors; however, persistently low SVR beyond 24 h was a 		  strong predictor of mortality. This study demonstrated that the majority of 		  patients (65%) who die of septic shock have a persistently low SVR, while a 		  smaller percentage die of low CO (10%) or of multiple organ failure (25%) after 		  hemodynamic resolution of shock. Although we did not evaluate serial 		  hemodynamic profiles in this study, our data identify a group of patients with 		  EHS who demonstrate a SVR below 450 dynes × s/cm5 and a mean CO 		  over 12l/min. As with patients in prior studies, this 		  group demonstrated a significantly higher mortality. Although the mechanisms 		  relating to the difference in mortality are unknown, it has been suggested that 		  patients with &quot;complicated&quot; shock (defined as multiorgan failure) 		  have greater distortions of cardiorespiratory patterns relative to the degree 		  of hypotension and that this is associated with a higher mortality </text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>13412</offset><text>Our study demonstrates that patients with sepsis syndrome are the most 		  common group of patients presenting with hypotension and a low SVR in the 		  medical intensive care unit. This group only represents approximately 40% of 		  patients in our study. While many of the remaining patients had some evidence 		  supporting the diagnosis of sepsis (eg fever, leukocytosis), they lacked an 		  identifiable source of infection, and the exact etiology of their hypotension 		  remains unknown. More significantly, almost one-quarter of the patients (24%) 		  in this study developed hypotension and a low SVR without any evidence of 		  sepsis. This group had a high mortality (46%), similar to the remaining 		  patients (54%). There were no significant differences in the clinical or 		  hemodynamic parameters between the nonseptic patients and the patients in the 		  remaining groups. The frequency of nonseptic causes of a low SVR suggest that 		  clinicians must be aware of conditions other than sepsis that have either been 		  well documented (Table 3) or reported to induce a 		  reduction in the SVR (Table 4).</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>14536</offset><text>The largest group of nonseptic patients in this study with hypotension 		  and a low SVR was found to be patients with decompensated cirrhosis. Although 		  occult infections should not be excluded, none of these patients had fever, 		  leukocytosis, an identifiable site of infection, or abnormalities in the 		  peritoneal fluid. Patients with liver cirrhosis often present with systemic 		  hemodynamic disturbances, including hypotension, low SVR, and a reduced 		  sensitivity to vasoconstrictors. The precise 		  mechanisms of these hemodynamic disorders have not yet been clearly elucidated. 		  Excessive production of vasodilators, peripheral shunts, and increased levels 		  of nitric oxide in these patients may contribute to the hyperdynamic state 		  observed in this population. A 		  recent study by Matsumoto demonstrated that 		  patients with decompensated liver cirrhosis had higher levels of exhaled nitric 		  oxide than patients with compensated cirrhosis, chronic liver disease, or 		  controls. The decompensated cirrhotics had a significantly higher CO and a 		  lower SVR than the compensated patients. Additionally, a positive correlation 		  was found between the level of nitric oxide and CI. Five of our patients with a 		  low SVR had decompensated liver disease as the presumed etiology of their 		  hypotension. Another five patients in the possible sepsis group had hypotension 		  with a clinical diagnosis of spontaneous bacterial peritonitis; however, the 		  lack of positive cultures, or any other evidence of infection, suggest that 		  decompensated liver disease may have played a significant role in their 		  hypotension.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>16202</offset><text>Pancreatitis was found to be the second most common cause of low SVR 		  in patients without evidence of infection. Three patients had necrotizing 		  pancreatitis, with one of these having evidence of hemorrhage into the 		  pancreas. Hemodynamic manifestations of pancreatitis include a normodynamic or 		  hypodynamic state, usually present in acute interstitial pancreatitis and 		  commonly associated with hypovolemia. Pancreatitis can also present as a 		  hyperdynamic state with high CO and a low SVR as described by Di Carlo et 		  al and Bradley et al. This hyperdynamic state is another manifestation of the 		  severity of acute pancreatitis and is seen mostly in necrotizing pancreatitis 		  with or without hemorrhage. Severe pancreatitis may 		  mimic sepsis syndrome or septic shock despite the absence of any infectious 		  site. The mechanisms responsible for pancreatic shock have not been elucidated; 		  however, an inflammatory cascade generalized by cytokines and TNF is felt to be 		  the most likely cause of this process.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>17251</offset><text>Adrenal insufficiency was found in one of our patients with no 		  evidence of infection. Unfortunately, cortisol levels and adrenocorticotrophic 		  hormone (ACTH) response was not routinely measured in patients with infection, 		  and adrenal insufficiency may have been underestimated in this group. Adrenal 		  insufficiency may present as a hypodynamic, normodynamic, or hyperdynamic state. The hypodynamic state is usually seen early in 		  adrenal insufficiency and is associated with volume depletion from diarrhea, 		  vomiting, and decreased reabsorption of sodium in the distal tubule. CO may 		  also be decreased in adrenal insufficiency as the result of the myofibrillar 		  adenosine triphosphate (ATP) depletion seen with glucocorticoid deficiency. Intravenous fluid therapy most often increases CO 		  and decreases SVR in patients with adrenal crisis. These patients are usually 		  separated from patients with sepsis by a baseline cortisol level below 10μ 		  g/dl or an inadequate response to ACTH. One of our 		  patients with septic shock had baseline cortisol of 22μ g/dl and no 		  response to the cosyntropin stimulation test. This patient could not be weaned 		  off high dose norepinephrine and dopamine until intravenous corticosteroids 		  were instituted. Normal values for basal and stimulated cortisol levels are 		  derived from the adrenal response of healthy individuals. Patients experiencing 		  the severe stress of critical illness demonstrate higher than normal amounts of 		  circulating cortisol. Some patients with critical illness have minimal or no 		  ACTH stimulation above their baseline cortisol levels and may be unable to 		  respond to additional physiologic stress. Several 		  reports suggest a significant number of critically ill patients may have 		  unrecognized adrenal insufficiency.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>19098</offset><text>Four cases of idiopathic hypotension with low SVR were identified in 		  our patients. One case was felt to be related to possible anaphylaxis or 		  anaphylactoid reaction but was not well documented. Silverman et al reported a patient who developed anaphylactic shock 		  secondary to penicillin 7days postmyocardial infarction; the hemodynamic 		  parameters showed a decrease in CO and MAP with an increase in SVR. Moss et 		  al reported the opposite hemodynamic profile 		  in a patient with anaphylactic shock secondary to succinycholine. Their patient 		  developed a low SVR and a high CO which correlated with increased levels of 		  histamine and catecholamines. Although there are minimal human data, animal 		  studies suggest there is an initial hypodynamic state secondary to severe 		  extravasation of fluids into the tissues followed by a hyperdynamic state after 		  fluid resuscitation.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>20005</offset><text>Our second case of hypotension with a low SVR presented in the setting 		  of an acute myocardial infarction. Although cardiogenic shock presents with a 		  high SVR and low CO, some data suggest that, rarely, patients may present with 		  a syndrome of low SVR. McCriskin et al  		  reported a patient with a left ventricular pseudoaneurysm postmyocardial 		  infarct with a low SVR and no evidence of infection. Costantin developed an animal model in dogs and demonstrated a 		  subset of animals with a hyperdynamic state after coronary occlusion; however, 		  Ross et al were unable to confirm these 		  results using another animal model. Similarly, Smith et al, in one of the original hemodynamic descriptions of 		  patients after myocardial infarction, did not identify any patient with a 		  hyperdynamic state. Another recently described cause of low SVR in cardiac 		  patients is the &quot;vasoplegic syndrome&quot;. This syndrome occurs within 		  6h after cardiac surgery using extracorporeal circulation. The incidence has been estimated between 0.4 and 5% of 		  patients undergoing cardiovascular surgery using cardiopulmonary bypass. The etiology is unclear but has 		  not been associated with increased levels of nitric oxide or endotoxin.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>21255</offset><text>One patient with a low SVR classified as idiopathic had a history of 		  significant alcohol consumption. Their initial hemodynamic parameters showed a 		  low SVR with high CO which rapidly resolved after intravenous thiamine and 		  broad-spectrum antibiotics. It is possible that this case represents a variant 		  of beriberi heart disease. This rare but treatable disease should be considered 		  in every patient with congestive heart failure and a low SVR. The fulminant 		  form known as Shosin beriberi presents as a high CO state with extremely high 		  CO and a low SVR which rapidly responds to thiamine.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>21872</offset><text>The remaining patient in the idiopathic group had no explanation for 		  their low SVR syndrome. Review of the literature shows many causes of a low SVR 		  (Tables 3 and 4), and it is 		  possible that one of these diagnosis was missed by the clinicians caring for 		  this patient. The patient had normal urine drug abuse screens and a normal 		  serum acetaminophen level. A salicylate level was not obtained. Leatherman and 		  Schmitz reported a series of five patients who 		  became accidentally intoxicated with salicylates with clinical, laboratory, and 		  hemodynamic features of sepsis, but without bacteriological evidence. In two of 		  the cases, TNF-α, IL-1 and IL-6 were measured and found to be 		  significantly elevated. Other drugs have been associated with a low SVR 		  including tricyclic antidepressants, anesthetic agents, and narcotics. Recently 		  Nguyen et al reported hyperdynamic shock 		  caused by trimethoprim-sulfamethoxazole in which immunoglobulin E antibodies 		  and TNF were not detected and complement levels were normal, suggesting a 		  mechanism other than anaphylaxis. Our drug screen should have identified 		  tricyclic antidepressants or narcotics in the urine; however, a careful drug 		  history was not elicited in this patient. Although other conditions such as 		  head injury, Paget's disease, arteriovenous fistula, severe anemia, multiple myeloma, 		  thyrotoxicosis, and spinal cord injury have been reported to produce a low SVR, this patient 		  lacked any clinical evidence suggesting one of these diagnoses; his hypotension 		  resolved spontaneously.</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>23490</offset><text>Mean hemodynamic values and mortality (±
			 SD)a</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Group&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;Number&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;MAP&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;CO&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;CI&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;SVR&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;Mortality&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Group 1: definitive sepsis&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;18&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;67.6 ± 22.7&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;10.19 ± 3.3&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;5.23 ± 1.5&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;455 ± 144&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;8/18 (44%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Group 2: probable sepsis&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;4&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;50.0 ± 27.6&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;9.83 ± 3.6&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;4.38 ± 1.9&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;506 ± 123&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;3/4 (75%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Group 3: possible sepsis&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;20&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;71.4 ± 15&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;9.70 ± 3.0&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;5.37 ± 1.6&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;483 ± 167&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;12/20 (60%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Group 4: nonseptic&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;13&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;74.7 ± 29&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;9.23 ± 4.2&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;4.72 ± 1.9&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;507 ± 222&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;6/13 (46%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Combined data&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;55&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;71.7 ± 20.8&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;9.76 ± 0.36&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;5.10 ± 1.7&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;435 ± 180&lt;/td&gt;&lt;td align=&quot;center&quot;&gt;29/55 (53%)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>23541</offset><text>Group	Number	MAP	CO	CI	SVR	Mortality	 	Group 1: definitive sepsis	18	67.6 ± 22.7	10.19 ± 3.3	5.23 ± 1.5	455 ± 144	8/18 (44%)	 	Group 2: probable sepsis	4	50.0 ± 27.6	9.83 ± 3.6	4.38 ± 1.9	506 ± 123	3/4 (75%)	 	Group 3: possible sepsis	20	71.4 ± 15	9.70 ± 3.0	5.37 ± 1.6	483 ± 167	12/20 (60%)	 	Group 4: nonseptic	13	74.7 ± 29	9.23 ± 4.2	4.72 ± 1.9	507 ± 222	6/13 (46%)	 	Combined data	55	71.7 ± 20.8	9.76 ± 0.36	5.10 ± 1.7	435 ± 180	29/55 (53%)	 	</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>24009</offset><text>MAP, mean arterial pressure (mmHg); CO, cardiac output (l/min);
				CI, (dynes × s/cm5). aP &gt; 0.05 for
				comparisons for hemodynamics and mortality between groups.</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>24176</offset><text>Documented conditions associated with low SVR</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Condition&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Comment&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Sepsis&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Most common cause of low SVR&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Pancreatitis&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Seen with necrotizing or hemorrhagic&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align=&quot;left&quot;&gt;pancreatitis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Cirrhosis&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Seen with decompensated liver disease&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Adrenal insufficiency&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Only 15 well documented cases&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Head injury&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Seen after initial rise in SVR&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Beriberi&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Rapid response to thiamine&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Salicylate (chronic)&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Seen in elderly patients, illness mimics sepsis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;TMP-SMX&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Reported only in AIDS patients&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Vasoplegic syndrome&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Occurs within 6 h postcardiopulmonary&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align=&quot;left&quot;&gt;bypass&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align=&quot;left&quot;&gt;Incidence estimated to be 0.4%-5.0%&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>24222</offset><text>Condition	Comment	 	Sepsis	Most common cause of low SVR	 	Pancreatitis	Seen with necrotizing or hemorrhagic	 		pancreatitis	 	Cirrhosis	Seen with decompensated liver disease	 	Adrenal insufficiency	Only 15 well documented cases	 	Head injury	Seen after initial rise in SVR	 	Beriberi	Rapid response to thiamine	 	Salicylate (chronic)	Seen in elderly patients, illness mimics sepsis	 	TMP-SMX	Reported only in AIDS patients	 	Vasoplegic syndrome	Occurs within 6 h postcardiopulmonary	 		bypass	 		Incidence estimated to be 0.4%-5.0%	 	</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>24757</offset><text>SVR, systemic vascular resistance (dynes × s/cm5);
				TMP-SMX, trimethoprim-sulfamethoxazole. See text for discussion.</text></passage><passage><infon key="file">T4.xml</infon><infon key="id">T4</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>24878</offset><text>Conditions reported to have low SVR</text></passage><passage><infon key="file">T4.xml</infon><infon key="id">T4</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Condition&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Comment&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Anaphylaxis&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Conflicting hemodynamic data; low SVR after&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align=&quot;left&quot;&gt;fluid repletion&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Myocardial infarction&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Rare, minimal evidence in humans&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Ovarian&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Hyperadrenergic and hypermetabolic state&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;hyperstimulation&lt;/td&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;syndrome/burns&lt;/td&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Thyrotoxicosis&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Animal studies only&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Multiple myeloma&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Three documented cases&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Anemia&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Hemoglobin &amp;lt; 7g; results not reproducible&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Hyperthermia&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Few well-documented cases&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Tricyclic&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Little hemodynamic data available&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;antidepressants&lt;/td&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Paget's disease&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Arterovenous shunts&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Spinal cord injury&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Injury above T6; inhibited vagal tone&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>24914</offset><text>Condition	Comment	 	Anaphylaxis	Conflicting hemodynamic data; low SVR after	 		fluid repletion	 	Myocardial infarction	Rare, minimal evidence in humans	 	Ovarian	Hyperadrenergic and hypermetabolic state	 	hyperstimulation		 	syndrome/burns		 	Thyrotoxicosis	Animal studies only	 	Multiple myeloma	Three documented cases	 	Anemia	Hemoglobin &lt; 7g; results not reproducible	 	Hyperthermia	Few well-documented cases	 	Tricyclic	Little hemodynamic data available	 	antidepressants		 	Paget's disease	Arterovenous shunts	 	Spinal cord injury	Injury above T6; inhibited vagal tone	 	</text></passage><passage><infon key="file">T4.xml</infon><infon key="id">T4</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>25491</offset><text>SVR, systemic vascular resistance in dynes ×
				s/cm5</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>25547</offset><text>Conclusion</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>25558</offset><text>In summary, we describe a group of 55 patients with a SVR below 		  800dynes×s/cm5, and a subgroup of 13 non-septic patents (24%) 		  with a similar mortality. This study emphasizes the importance of considering 		  other conditions besides sepsis in patients presenting with hypotension and a 		  low SVR.</text></passage><passage><infon key="fpage">1644</infon><infon key="lpage">1655</infon><infon key="name_0">surname:Bone;given-names:RC</infon><infon key="name_1">surname:Balk;given-names:RA</infon><infon key="name_2">surname:Cerra;given-names:FB</infon><infon key="pub-id_pmid">1303622</infon><infon key="section_type">REF</infon><infon key="source">Chest</infon><infon key="type">ref</infon><infon key="volume">101</infon><infon key="year">1992</infon><offset>25866</offset><text>Definitions for sepsis and organ failure and guidelines for the use 			 of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference 			 Committee, American College of Chest Physicians/Socity of Critical Care 			 Medicine.</text></passage><passage><infon key="fpage">245</infon><infon key="lpage">249</infon><infon key="name_0">surname:Baumgartner;given-names:JD</infon><infon key="name_1">surname:Vaney;given-names:C</infon><infon key="name_2">surname:Perret;given-names:C</infon><infon key="section_type">REF</infon><infon key="source">Int Care Med</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">1984</infon><offset>26098</offset><text>An extreme form of they hyperdynamic syndrome in septic shock.</text></passage><passage><infon key="fpage">421</infon><infon key="lpage">432</infon><infon key="name_0">surname:Winslow;given-names:E</infon><infon key="name_1">surname:Loeb;given-names:H</infon><infon key="name_2">surname:Rahimtoola;given-names:S</infon><infon key="pub-id_pmid">4696004</infon><infon key="section_type">REF</infon><infon key="source">Am J Med</infon><infon key="type">ref</infon><infon key="volume">54</infon><infon key="year">1973</infon><offset>26161</offset><text>Hemodynamic studies and results of therapy in 50 patients with 			 bacteremic shock. </text></passage><passage><infon key="fpage">227</infon><infon key="lpage">242</infon><infon key="name_0">surname:Parillo;given-names:JE</infon><infon key="name_1">surname:Parker;given-names:MM</infon><infon key="name_2">surname:Natanson;given-names:C</infon><infon key="pub-id_pmid">2197912</infon><infon key="section_type">REF</infon><infon key="source">Ann Intern Med</infon><infon key="type">ref</infon><infon key="volume">113</infon><infon key="year">1990</infon><offset>26247</offset><text>Septic shock in humans: advances in the understanding of 			 pathogenesis, cardiovascular dysfunction, and therapy.</text></passage><passage><infon key="fpage">1542</infon><infon key="lpage">1553</infon><infon key="name_0">surname:Parillo;given-names:JE</infon><infon key="name_1">surname:Burch;given-names:C</infon><infon key="name_2">surname:Shelhamer;given-names:JH</infon><infon key="section_type">REF</infon><infon key="source">J Clin Invest</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="year">1985</infon><offset>26363</offset><text>A circulating myocardial depressant substance in humans with septic 			 shock.</text></passage><passage><infon key="fpage">697</infon><infon key="lpage">705</infon><infon key="name_0">surname:Weber;given-names:KT</infon><infon key="name_1">surname:Ratshin;given-names:RA</infon><infon key="name_2">surname:Janicki;given-names:JS</infon><infon key="pub-id_pmid">4267493</infon><infon key="section_type">REF</infon><infon key="source">Am J Med</infon><infon key="type">ref</infon><infon key="volume">54</infon><infon key="year">1973</infon><offset>26442</offset><text>Left ventricular dysfunction following acute myocardial 			 infarction.</text></passage><passage><infon key="fpage">923</infon><infon key="lpage">929</infon><infon key="name_0">surname:Parker;given-names:M</infon><infon key="name_1">surname:Shelhamer;given-names:JH</infon><infon key="name_2">surname:Natanson;given-names:C</infon><infon key="pub-id_pmid">3652707</infon><infon key="section_type">REF</infon><infon key="source">Crit Care Med </infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">1987</infon><offset>26514</offset><text>Serial cardiovascular variables in survivors and nonsurvivors of 			 human septic shock: heart rate as an early predictor of prognosis. </text></passage><passage><infon key="fpage">245</infon><infon key="lpage">254</infon><infon key="name_0">surname:Shoemaker;given-names:WC</infon><infon key="name_1">surname:Mohr;given-names:PA</infon><infon key="name_2">surname:Printen;given-names:KJ</infon><infon key="pub-id_pmid">5433842</infon><infon key="section_type">REF</infon><infon key="source">Surg Gynecol Obstet</infon><infon key="type">ref</infon><infon key="volume">131</infon><infon key="year">1970</infon><offset>26651</offset><text>Use of sequential physiologic measurements as guides in therapy of 			 uncomplicated septic shock.</text></passage><passage><infon key="fpage">119</infon><infon key="lpage">125</infon><infon key="name_0">surname:Shoemaker;given-names:WC</infon><infon key="pub-id_pmid">5092499</infon><infon key="section_type">REF</infon><infon key="source">Ann Surg</infon><infon key="type">ref</infon><infon key="volume">174</infon><infon key="year">1971</infon><offset>26750</offset><text>Cardiorespiratory patterns in complicated and uncomplicated septic 			 shock: physiologic alterations and their therapeutic implications.</text></passage><passage><infon key="fpage">505</infon><infon key="lpage">519</infon><infon key="name_0">surname:Moller;given-names:S</infon><infon key="name_1">surname:Henriksen;given-names:JH</infon><infon key="pub-id_pmid">9353862</infon><infon key="section_type">REF</infon><infon key="source">Semin Nephrol</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">1997</infon><offset>26888</offset><text>Circulatory abnormalities in cirrhosis with focus on neurohumoral 			 aspects.</text></passage><passage><infon key="fpage">365</infon><infon key="lpage">367</infon><infon key="name_0">surname:Sherlock;given-names:S</infon><infon key="pub-id_pmid">2186977</infon><infon key="section_type">REF</infon><infon key="source">Gut</infon><infon key="type">ref</infon><infon key="volume">31</infon><infon key="year">1990</infon><offset>26967</offset><text>Vasodilatation associated with hepatocellular disease: relation to 			 functional organ failure.</text></passage><passage><infon key="fpage">1139</infon><infon key="lpage">1145</infon><infon key="name_0">surname:Fernandez-Rodriguez;given-names:CM</infon><infon key="name_1">surname:Prieto;given-names:J</infon><infon key="name_2">surname:Zozaya;given-names:JM</infon><infon key="pub-id_pmid">8462804</infon><infon key="section_type">REF</infon><infon key="source">Gastroenterology</infon><infon key="type">ref</infon><infon key="volume">104</infon><infon key="year">1993</infon><offset>27064</offset><text>Arteriovenous shunting, hemodynamic changes, and renal sodium 			 retention in liver cirrhosis.</text></passage><passage><infon key="fpage">1024</infon><infon key="lpage">1029</infon><infon key="name_0">surname:Lewis;given-names:FW</infon><infon key="name_1">surname:Adair;given-names:O</infon><infon key="name_2">surname:Rector;given-names:W</infon><infon key="pub-id_pmid">1537494</infon><infon key="section_type">REF</infon><infon key="source">Gastroenterology </infon><infon key="type">ref</infon><infon key="volume">102</infon><infon key="year">1992</infon><offset>27160</offset><text>Arterial vasodilation is not the cause of increased cardiac output 			 in cirrhosis.</text></passage><passage><infon key="fpage">3079</infon><infon key="lpage">3082</infon><infon key="name_0">surname:Smith;given-names:REA</infon><infon key="name_1">surname:Robinson;given-names:NMK</infon><infon key="name_2">surname:McPeake;given-names:JR</infon><infon key="pub-id_pmid">9409296</infon><infon key="section_type">REF</infon><infon key="source">Arterioscler Thromb Vasc Biol</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">1997</infon><offset>27245</offset><text>Induction and role of NO synthase in hypotensive hepatic failure. 			 </text></passage><passage><infon key="fpage">968</infon><infon key="lpage">970</infon><infon key="name_0">surname:Friedman;given-names:HS</infon><infon key="name_1">surname:Fernando;given-names:H</infon><infon key="pub-id_pmid">1443437</infon><infon key="section_type">REF</infon><infon key="source">Alcohol Clin Exp Res </infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">1992</infon><offset>27316</offset><text>Ascites as a marker for the hyperdynamic heart of Laennec's 			 cirrhosis.</text></passage><passage><infon key="fpage">110</infon><infon key="lpage">113</infon><infon key="name_0">surname:Matsumoto;given-names:A</infon><infon key="pub-id_pmid">7778822</infon><infon key="section_type">REF</infon><infon key="source">Ann Intern Med</infon><infon key="type">ref</infon><infon key="volume">123</infon><infon key="year">1995</infon><offset>27391</offset><text>Increased nitric oxide in the exhaled air of patients with 			 decompensated liver cirrhosis.</text></passage><passage><infon key="fpage">329</infon><infon key="lpage">339</infon><infon key="name_0">surname:Di Carlo;given-names:V</infon><infon key="name_1">surname:Nespoli;given-names:A</infon><infon key="name_2">surname:Chiesa;given-names:R</infon><infon key="pub-id_pmid">7293195</infon><infon key="section_type">REF</infon><infon key="source">World J Surg</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">1981</infon><offset>27485</offset><text>Hemodynamic and metabolic impairment in acute pancreatitis.</text></passage><passage><infon key="fpage">130</infon><infon key="lpage">133</infon><infon key="name_0">surname:Bradley;given-names:EL</infon><infon key="name_1">surname:Hall;given-names:JR</infon><infon key="name_2">surname:Lutz;given-names:J</infon><infon key="pub-id_pmid">6870367</infon><infon key="section_type">REF</infon><infon key="source">Ann Surg</infon><infon key="type">ref</infon><infon key="volume">198</infon><infon key="year">1983</infon><offset>27545</offset><text>Hemodynamic consequences of severe pancreatitis.</text></passage><passage><infon key="fpage">74</infon><infon key="lpage">79</infon><infon key="name_0">surname:Beger;given-names:HG</infon><infon key="name_1">surname:Bittner;given-names:R</infon><infon key="name_2">surname:Buchler;given-names:M</infon><infon key="pub-id_pmid">3940259</infon><infon key="section_type">REF</infon><infon key="source">Gastroenterology </infon><infon key="type">ref</infon><infon key="volume">90</infon><infon key="year">1986</infon><offset>27594</offset><text>Hemodynamic data pattern in patients with acute pancreatitis.</text></passage><passage><infon key="fpage">138</infon><infon key="lpage">141</infon><infon key="name_0">surname:Bouachour;given-names:G</infon><infon key="name_1">surname:Tirot;given-names:P</infon><infon key="name_2">surname:Varache;given-names:N</infon><infon key="section_type">REF</infon><infon key="source">Int Care Med</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">1994</infon><offset>27656</offset><text>Hemodynamic changes in acute adrenal insufficiency.</text></passage><passage><infon key="fpage">673</infon><infon key="lpage">676</infon><infon key="name_0">surname:Baldwin;given-names:WA</infon><infon key="name_1">surname:Allo;given-names:M</infon><infon key="pub-id_pmid">8503772</infon><infon key="section_type">REF</infon><infon key="source">Arch Surg</infon><infon key="type">ref</infon><infon key="volume">128</infon><infon key="year">1993</infon><offset>27708</offset><text>Occult hypoadrenalism in critically ill patients.</text></passage><passage><infon key="fpage">29</infon><infon key="lpage">33</infon><infon key="name_0">surname:Sibbald;given-names:WJ</infon><infon key="name_1">surname:Short;given-names:A</infon><infon key="name_2">surname:Cohen;given-names:MP</infon><infon key="pub-id_pmid">195542</infon><infon key="section_type">REF</infon><infon key="source">Ann Surg</infon><infon key="type">ref</infon><infon key="volume">186</infon><infon key="year">1977</infon><offset>27758</offset><text>Variations in adrenocortical responsiveness during severe bacterial 			 infections. </text></passage><passage><infon key="fpage">414</infon><infon key="lpage">1415</infon><infon key="name_0">surname:Finlay;given-names:WEI</infon><infon key="name_1">surname:McKee;given-names:JI</infon><infon key="section_type">REF</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><infon key="volume">1</infon><infon key="year">1982</infon><offset>27843</offset><text>Serum cortisol levels in severely stressed patients.</text></passage><passage><infon key="fpage">94</infon><infon key="lpage">100</infon><infon key="name_0">surname:Claussen;given-names:MS</infon><infon key="name_1">surname:Landercasper;given-names:J</infon><infon key="name_2">surname:Cogbill;given-names:TH</infon><infon key="pub-id_pmid">1732582</infon><infon key="section_type">REF</infon><infon key="source">J Trauma</infon><infon key="type">ref</infon><infon key="volume">31</infon><infon key="year">1992</infon><offset>27896</offset><text>Acute adrenal insufficiency after trauma and surgery.</text></passage><passage><infon key="fpage">341</infon><infon key="lpage">344</infon><infon key="name_0">surname:Silverman;given-names:HJ</infon><infon key="name_1">surname:Van Hook;given-names:C</infon><infon key="name_2">surname:Haponik;given-names:EF</infon><infon key="pub-id_pmid">6465179</infon><infon key="section_type">REF</infon><infon key="source">Am J Med</infon><infon key="type">ref</infon><infon key="volume">77</infon><infon key="year">1994</infon><offset>27950</offset><text>Hemodynamic changes in human anaphylaxis.</text></passage><passage><infon key="fpage">210</infon><infon key="lpage">213</infon><infon key="name_0">surname:Moss;given-names:J</infon><infon key="name_1">surname:Fahmy;given-names:NR</infon><infon key="name_2">surname:Sunder;given-names:N</infon><infon key="pub-id_pmid">7002360</infon><infon key="section_type">REF</infon><infon key="source">Circulation </infon><infon key="type">ref</infon><infon key="volume">63</infon><infon key="year">1981</infon><offset>27992</offset><text>Hormonal and hemodynamic profile of an anaphylactic reaction in 			 man.</text></passage><passage><infon key="fpage">577</infon><infon key="lpage">579</infon><infon key="name_0">surname:McCriskin;given-names:JW</infon><infon key="name_1">surname:Baisden;given-names:CE</infon><infon key="name_2">surname:Spaccevento;given-names:LJ</infon><infon key="pub-id_pmid">3661592</infon><infon key="section_type">REF</infon><infon key="source">Am J Med</infon><infon key="type">ref</infon><infon key="volume">83</infon><infon key="year">1987</infon><offset>28065</offset><text>Pseudosepsis after myocardial infarction.</text></passage><passage><infon key="fpage">205</infon><infon key="lpage">217</infon><infon key="name_0">surname:Costantin;given-names:L</infon><infon key="pub-id_pmid">14023293</infon><infon key="section_type">REF</infon><infon key="source">Am J Cardiol</infon><infon key="type">ref</infon><infon key="year">1963</infon><offset>28107</offset><text>Extracardiac factors contributing to hypotension during coronary 			 occlusion.</text></passage><passage><infon key="fpage">563</infon><infon key="lpage">572</infon><infon key="name_0">surname:Ross;given-names:J</infon><infon key="name_1">surname:Frahm;given-names:CJ</infon><infon key="name_2">surname:Braunwald;given-names:E</infon><infon key="pub-id_pmid">16695855</infon><infon key="section_type">REF</infon><infon key="source">J Clin Invest</infon><infon key="type">ref</infon><infon key="volume">40</infon><infon key="year">1961</infon><offset>28187</offset><text>The influence of intracardiac baroreceptors on venous return, 			 systemic vascular volume and peripheral resistance.</text></passage><passage><infon key="fpage">352</infon><infon key="lpage">362</infon><infon key="name_0">surname:Smith;given-names:W</infon><infon key="name_1">surname:Wikler;given-names:NS</infon><infon key="name_2">surname:Fox;given-names:AC</infon><infon key="pub-id_pmid">13141363</infon><infon key="section_type">REF</infon><infon key="source">Circulation</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">1954</infon><offset>28305</offset><text>Hemodynamic studies of patients with myocardial infarction.</text></passage><passage><infon key="fpage">619</infon><infon key="lpage">623</infon><infon key="name_0">surname:Gomes;given-names:WJ</infon><infon key="name_1">surname:Carvalho;given-names:AC</infon><infon key="name_2">surname:Palma;given-names:JH</infon><infon key="pub-id_pmid">9833722</infon><infon key="section_type">REF</infon><infon key="source">J Cardiovasc Surg</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="year">1998</infon><offset>28365</offset><text>Vasoplegic syndrome after open heart surgery.</text></passage><passage><infon key="fpage">571</infon><infon key="lpage">574</infon><infon key="name_0">surname:Myles;given-names:PS</infon><infon key="name_1">surname:Leong;given-names:CK</infon><infon key="name_2">surname:Currey;given-names:J</infon><infon key="pub-id_pmid">9263087</infon><infon key="section_type">REF</infon><infon key="source">J Cardiothorac Vasc Anesth</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">1997</infon><offset>28411</offset><text>Endogenous nitric oxide and low systemic vascular resistance after 			 cardiopulmonary bypass.</text></passage><passage><infon key="fpage">263</infon><infon key="lpage">265</infon><infon key="name_0">surname:Ayzenbert;given-names:O</infon><infon key="name_1">surname:Silber;given-names:MH</infon><infon key="name_2">surname:Bortz;given-names:D</infon><infon key="pub-id_pmid">4035486</infon><infon key="section_type">REF</infon><infon key="source">S Afr Med J</infon><infon key="type">ref</infon><infon key="volume">68</infon><infon key="year">1985</infon><offset>28506</offset><text>Beriberi heart disease: a case report describing the haemodynamic 			 features.</text></passage><passage><infon key="fpage">1467</infon><infon key="name_0">surname:Pereira;given-names:VG</infon><infon key="name_1">surname:Masuda;given-names:Z</infon><infon key="name_2">surname:Katz;given-names:A</infon><infon key="pub-id_pmid">6720597</infon><infon key="section_type">REF</infon><infon key="source">Am J Cardiol</infon><infon key="type">ref</infon><infon key="volume">53</infon><infon key="year">1984</infon><offset>28586</offset><text>Shoshin beriberi: report of two successfully treated patients with 			 hemodynamic documentation.</text></passage><passage><infon key="fpage">383</infon><infon key="lpage">386</infon><infon key="name_0">surname:Kawai;given-names:C</infon><infon key="name_1">surname:Wakabayashi;given-names:A</infon><infon key="name_2">surname:Matsumura;given-names:T</infon><infon key="pub-id_pmid">7416185</infon><infon key="section_type">REF</infon><infon key="source">Am J Med</infon><infon key="type">ref</infon><infon key="volume">69</infon><infon key="year">1980</infon><offset>28684</offset><text>Reappearance of beriberi heart disease in Japan: a study of 23 			 cases.</text></passage><passage><infon key="fpage">1391</infon><infon key="lpage">1396</infon><infon key="name_0">surname:Leatherman;given-names:JW</infon><infon key="name_1">surname:Schmitz;given-names:PG</infon><infon key="pub-id_pmid">1935299</infon><infon key="section_type">REF</infon><infon key="source">Chest</infon><infon key="type">ref</infon><infon key="volume">100</infon><infon key="year">1991</infon><offset>28758</offset><text>Fever, hyperdynamic shock, and multiple-system organ failure: a 			 pseudosepsis syndrome associated with chronic salicylate intoxication.</text></passage><passage><infon key="fpage">885</infon><infon key="lpage">887</infon><infon key="name_0">surname:Nguyen;given-names:B</infon><infon key="name_1">surname:Landucci;given-names:DL</infon><infon key="name_2">surname:Cunnion;given-names:RE</infon><infon key="pub-id_pmid">8286631</infon><infon key="section_type">REF</infon><infon key="source">Clin Infect Dis</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">1993</infon><offset>28897</offset><text>A case of hyperdynamic shock caused by trimethoprim-sulfamethoxazole 			 in which no tumor necrosis factor or features of anaphylaxis were detected.</text></passage><passage><infon key="fpage">1205</infon><infon key="lpage">1211</infon><infon key="name_0">surname:Brown;given-names:RS</infon><infon key="name_1">surname:Mohr;given-names:PA</infon><infon key="name_2">surname:Carey;given-names:JS</infon><infon key="pub-id_pmid">6065257</infon><infon key="section_type">REF</infon><infon key="source">Surg Gynecol Obstet</infon><infon key="type">ref</infon><infon key="volume">125</infon><infon key="year">1967</infon><offset>29046</offset><text>Cardiovascular changes after cranial cerebral injury and increased 			 intracranial pressure. </text></passage><passage><infon key="fpage">187</infon><infon key="lpage">192</infon><infon key="name_0">surname:Brown;given-names:RS</infon><infon key="name_1">surname:Shoemaker;given-names:WC</infon><infon key="pub-id_pmid">4698537</infon><infon key="section_type">REF</infon><infon key="source">Ann Surg</infon><infon key="type">ref</infon><infon key="volume">177</infon><infon key="year">1973</infon><offset>29141</offset><text>Sequential hemodynamic changes in patients with head injury: 			 evidence for an early hemodynamic defect. </text></passage><passage><infon key="fpage">447</infon><infon key="lpage">454</infon><infon key="name_0">surname:Clifton;given-names:GS</infon><infon key="name_1">surname:Robertson;given-names:CS</infon><infon key="name_2">surname:Kyper;given-names:K</infon><infon key="pub-id_pmid">6886758</infon><infon key="section_type">REF</infon><infon key="source">J Neurosurg </infon><infon key="type">ref</infon><infon key="volume">59</infon><infon key="year">1983</infon><offset>29249</offset><text>Cardiovascular response to severe head injury.</text></passage><passage><infon key="fpage">390</infon><infon key="lpage">397</infon><infon key="name_0">surname:Henley;given-names:JW</infon><infon key="name_1">surname:Croxson;given-names:RJ</infon><infon key="name_2">surname:Ibbertson;given-names:HK</infon><infon key="pub-id_pmid">292378</infon><infon key="section_type">REF</infon><infon key="source">Aust N Z J Med</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">1979</infon><offset>29296</offset><text>The cardiovascular system in Paget's disease of bone and the 			 response to therapy with calcitonin and diphosphonate.</text></passage><passage><infon key="fpage">711</infon><infon key="lpage">726</infon><infon key="name_0">surname:Sgrnberger;given-names:CF</infon><infon key="name_1">surname:Smedal;given-names:MI</infon><infon key="section_type">REF</infon><infon key="source">Circulation</infon><infon key="type">ref</infon><infon key="volume">VI</infon><infon key="year">1952</infon><offset>29416</offset><text>The mechanism and incidence of cardiovascular changes in 			 Paget's disease (osteitis deformans): a critical review of the literature 			 with case studies.</text></passage><passage><infon key="fpage">215</infon><infon key="lpage">219</infon><infon key="name_0">surname:Lequime;given-names:J</infon><infon key="name_1">surname:Denolin;given-names:H</infon><infon key="pub-id_pmid">13240802</infon><infon key="section_type">REF</infon><infon key="source">Circulation</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">1955</infon><offset>29574</offset><text>Circulatory dynamics in osteitis deformans.</text></passage><passage><infon key="fpage">564</infon><infon key="lpage">567</infon><infon key="name_0">surname:Sanyal;given-names:S</infon><infon key="name_1">surname:Saldivar;given-names:V</infon><infon key="name_2">surname:Coburn;given-names:TP</infon><infon key="pub-id_pmid">177939</infon><infon key="section_type">REF</infon><infon key="source">Pediatrics</infon><infon key="type">ref</infon><infon key="volume">57</infon><infon key="year">1976</infon><offset>29618</offset><text>Hyperdynamic heart failure due to A-V fistula associated with 			 Wilms' tumor. </text></passage><passage><infon key="fpage">332</infon><infon key="lpage">336</infon><infon key="name_0">surname:Brannon;given-names:ES</infon><infon key="name_1">surname:Merrill;given-names:AJ</infon><infon key="name_2">surname:Warren;given-names:JV</infon><infon key="pub-id_pmid">16695220</infon><infon key="section_type">REF</infon><infon key="source">J Clin Invest</infon><infon key="type">ref</infon><infon key="volume">24</infon><infon key="year">1945</infon><offset>29699</offset><text>The cardiac output in patients with chronic anemia as measured by 			 the technique of right atrial catheterization.</text></passage><passage><infon key="fpage">415</infon><infon key="lpage">446</infon><infon key="name_0">surname:Varat;given-names:MA</infon><infon key="name_1">surname:Adolph;given-names:RJ</infon><infon key="name_2">surname:Fowler;given-names:NO</infon><infon key="pub-id_pmid">4551028</infon><infon key="section_type">REF</infon><infon key="source">Am Heart J</infon><infon key="type">ref</infon><infon key="volume">83</infon><infon key="year">1972</infon><offset>29816</offset><text>Cardiovascular effects of anemia.</text></passage><passage><infon key="fpage">1651</infon><infon key="lpage">1653</infon><infon key="name_0">surname:McBride;given-names:W</infon><infon key="name_1">surname:Jackman JD;given-names:Jr</infon><infon key="name_2">surname:Gammon;given-names:RS</infon><infon key="pub-id_pmid">3200279</infon><infon key="section_type">REF</infon><infon key="source">N Engl J Med </infon><infon key="type">ref</infon><infon key="volume">319</infon><infon key="year">1988</infon><offset>29850</offset><text>High output cardiac failure in patients with multiple myeloma.</text></passage><passage><infon key="fpage">358</infon><infon key="lpage">365</infon><infon key="name_0">surname:Goldman;given-names:S</infon><infon key="name_1">surname:Olajos;given-names:M</infon><infon key="name_2">surname:Morkin;given-names:E</infon><infon key="section_type">REF</infon><infon key="source">J ClinInvest</infon><infon key="type">ref</infon><infon key="volume">73</infon><infon key="year">1984</infon><offset>29913</offset><text>Control of cardiac output in thyrotoxic calves.</text></passage><passage><infon key="fpage">291</infon><infon key="lpage">302</infon><infon key="name_0">surname:Tator;given-names:CH</infon><infon key="section_type">REF</infon><infon key="source">Neurochirugie</infon><infon key="type">ref</infon><infon key="volume">37</infon><infon key="year">1991</infon><offset>29961</offset><text>Review of experimental spinal cord injury with emphasis on the local 			 and systemic circulatory changes </text></passage></document></collection>
